Dear Investors, Partners, and Esteemed Customers,
As Chairman of Virgil Healthcare, advancing healthcare through Innovation & trust, it is both a privilege and a responsibility to guide a company at the forefront of diagnostic innovation. Today, I write to share our vision, celebrate our collective achievements, and reaffirm our commitment to transforming healthcare through high-speed precision, accessibility, and technological excellence.
The Virgil Promise: Where Vision Meets Impact
Healthcare is evolving rapidly, and diagnostics lie at its heart. At Virgil, we recognize that accurate, timely, and affordable testing is not just a medical necessity—it is a fundamental human right. Our mission is to democratize access to world-class diagnostics, ensuring that every patient, in every corner of the world, benefits from cutting-edge science.
For our investors, Virgil represents a rare convergence of social impact and sustainable growth. Our patented OnS!te® Minilabs and AI-driven cancer diagnostics are not just breakthroughs; they are scalable solutions addressing critical gaps in global healthcare. With FDA/CE approvals, strategic alliances, and a pipeline of disruptive technologies, we are poised to redefine the diagnostics landscape.
To our customers and partners, we extend our deepest gratitude. Your trust inspires us to push boundaries daily. Whether you are a clinician relying on our rapid POC tests, a researcher leveraging our biomarkers, or a hospital system integrating our platforms, your success is our ultimate metric.
Excited to be ahead of Strategic Growth
Our Pillars of Excellence
A Call to Collective Action
The road ahead is both exciting and demanding. To our investors, we invite you to deepen your engagement—explore our pipeline, visit our labs, and join our mission. To our customers, we pledge relentless improvement; your feedback is our compass.
Together, we can turn the promise of high-speed precision healthcare into a reality for millions. Learn more at www.virgilhealthcare.com or connect with me at info@virgilhealthcare.com.
With unwavering commitment,
Dr. Harshavardhan Hegde
Chairman of the Board
Virgil Healthcare
Diagnostics with Integrity……..Innovation with Purpose.
Dear Valued Investors, Customers, Partners, and Team,
At Virgil Healthcare, pioneering the future of diagnostics, we stand at the intersection of innovation and impact, driven by a singular mission: to transform global healthcare through precision and high-speed diagnostics. As CEO, I am honored to share our vision, progress, and unwavering commitment to advancing medical testing for clinicians, patients, and communities worldwide.
In an era where timely and accurate diagnostics can mean the difference between life and death, we are redefining what’s possible. Our cutting-edge high speed diagnostic solutions—from rapid point-of-care testing (OnS!te® Minilabs) to AI-powered cancer screening—are designed to bridge critical gaps in healthcare access, speed, and affordability.
For our investors, Virgil represents a unique opportunity to back a company that combines breakthrough technology with scalable impact. Our patented biomarkers, CLIA-waived platforms, and strategic partnerships position us to lead the next wave of diagnostic innovation—with measurable clinical and financial returns. Thank you for your trust and partnership. Your support enables us to push boundaries, invest in groundbreaking research, and deliver sustainable growth.
For customers and partners, we pledge reliability, speed, and actionable insights. Whether you’re a hospital seeking faster turnaround times, a rural clinic overcoming resource constraints, or a researcher pushing the boundaries of precision medicine, Virgil is your trusted ally.
And to our employees, your dedication is our greatest strength. Your passion and expertise drive our success—thank you for making Virgil Healthcare a leader in our industry.
As we look ahead, we remain steadfast in our mission, guided by integrity and a vision for transformative impact. The road forward is filled with opportunity, and I am grateful to have you alongside us.
Our Milestones
A Commitment to Excellence
Join us as we build a future where no patient waits for answers, no disease goes undetected, and no community is left behind. Explore our latest advancements at www.virgilhealthcare.com or reach me directly at info@virgilhealthcare.com.
With gratitude and resolve,
Venkatesh Kallur
Chief Executive Officer & Board Member
Virgil Healthcare
High-speed Precision Diagnostics………….Empowering Lives
Our Professional Team
A dedicated group of experts committed to delivering exceptional
service and unparalleled results
Dr. Rohit Dwivedi
Dr. Rohit Dwivedi, M.D, Phenix, Arizona, USA
M.D, Phenix, Arizona, USA
Experienced Clinician with a demonstrated history of working in the Medical Industry. Strong education professional skilled in Clinical Research, Medical Education, and Clinical Medicine.
Graduate of The Ohio State University College of Medicine, he completed his internship and Endocrinology fellowship at Indiana University.
He has been in clinical practice for over 20 years and has run a Clia-certified physician laboratory for over 15 years. He has extensive ties with the medical industry as Chief Medical officer of numerous organizations, consultant with Silicon Valley firms, such as Medikarma.Ai and has also help found disruptive companies such as Claracare
Rahul Bhattacharya
Rahul Bhattacharya
Co-founder of Microgravity
Co-founder of Microgravity Ventures with 24 years of corporate experience, including 11 years at Accenture India.
Built a gaming. enterprise from scratch He managed P&L through multiple sales and operating cycles for innovation led start-ups and professional services firm for clients in India, APAC, Middle East and Americas.
He has successfully Incubated & managed new products and innovation. He carries cross-industry complex deal-making expertise – Telecom, Technology, Financial Services and Government. His other strengths being in Client relationship and solving for growth and profitability challenges, Establish Strategic partnerships and alliances and Spearheading Business Transformation, Strategic Outsourcing and Value Based programs.
Dr. Ashok Vaid
Dr. Ashok Vaid
Oncology Chairman at Medanta Group
Oncology Chairman at Medanta Group with a distinguished career in cancer care. A Padma Shri Awardee for his contributions to Medicine, Dr. Ashok Vaid is a renowned medical oncologist, known for his pioneering efforts in bone marrow transplantation in India.
He is credited with the performance of the first 25 bone marrow transplantations in the private sector in North India.
Dr. Ashok Vaid is an Oncologist/Cancer Specialist with 28 years of expertise in this profession. He earned an MBBS from the University of Jammu in 1984, an MD in Internal Medicine from the same university in 1989, and a DM in Oncology from Dr. MGR Medical University in Chennai, India, in 1993.
Furthermore, he has decades of clinical experience, with a focus on cancer genomics, immunotherapy guidance, and precision onco-therapeutics, as well as dendritic cell treatment and stem cell transplantation. Meanwhile, he is a postgraduate instructor registered with the National Board of Examinations and serves on the panel of university examiners for the super-specialty course Medical Oncology.
Venkatesh Kallur
Venkatesh Kallur
Global Leader in Strategy, Risk Management, Cybersecurity & Financial Services
Venkatesh Kallur is a visionary leader with over 30 years of transformative impact in international banking, financial services, and risk management. Renowned for his strategic foresight and operational excellence, he has shaped resilient, future-ready organizations as Chief Executive Officer (CEO) and Chief Risk Officer (CRO) across financial and healthcare institutions.
His expertise spans cyber resilience, digital transformation risk mitigation, and sustainable governance, making him a trusted authority in safeguarding enterprises against evolving global threats.
Leadership in Risk & Strategy
Thought Leadership & Influence
Mentorship & Legacy Building
Recognition & Cross-Sector Impact
Kallur’s work has been celebrated across banking, healthcare, and technology sectors, with accolades underscoring his multidisciplinary influence in
Dr. Harshavardhan Hegde
Dr. Harshavardhan Hegde
Director and leading Orthopaedic surgeon
Director and leading Orthopaedic surgeon, with the Max Group of Hospitals. Practice in India and the Middle-east.
With over 3 decades of experience post M.S.(Ortho), which he completed from Baroda Medical College in 1987, he gathered clinical experience overseas with fellowships in prestigious institutions like Nuffield Orthopedic Centre in Oxford, UK and Klinikum Karlsbaad, Germany - one of world’s premier institution for spinal surgery. He has also undertaken specific specialist training in US, Australia, Brussels and Budapest.
In India, he taught undergraduate and post graduate students in Pramukh Swami Medical College at Karamsad Gujarat where he served as the Professor & Head of Orthopedics. After heading the Orthopedic units in Alembic Hospital, Vadodara and Apollo Hospital in Gandhinagar, he moved to New Delhi in 2005 with Max Hospitals at Patparganj and have done stints at multiple corporate hospitals in the city eg Artemis Hospital Gurgaon, Nova Bone & Joint Hospital and Fortis Vasant Kunj. Dr.Hegde is one of the first persons in the country to do robotic spinal surgery in 2013. He is a regular visitor to the Sultanate of Oman for over a decade as a Senior Consultant, Spine & Orthopedics. He operated extensively in Middle East, Iraq and Africa and have a large patient base from these countries.